Novartis (nyse: NVS - news - people ) is also studying its drug Zometa, used to treat erosion of bone due to cancer, against rheumatoid arthritis.

FORBES: Magazine Article

Novartis (nyse: NVS - news - people ) is studying Zometa--its drug used to treat erosion of bone caused by cancer--for its effectiveness against rheumatoid arthritis.

FORBES: Race for comfort